SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2307Exactly, all the analysts just try to pump up share price so they can dump. I aFelix B-2/15/2018
2306Unconditionally, trust (and love) your analyst report (whatever brokerage house)Miljenko Zuanic22/15/2018
2305Well, add PFE (and LLY/INCY) into pool of the "me too" BKT drugs forMiljenko Zuanic-2/14/2018
2304Are REGN's prospects that much dimmer than they were in 2015 or 2016? Or isThe Ox-2/14/2018
2303They are continuously late to any new or re-discovered target (IL-4R was re-discMiljenko Zuanic-2/13/2018
2302A few years too late into oncology targets beyond VEGF. Where are the bi-specifBiotech Jim-2/13/2018
2301IF EYLEA IS $1B BY 2023, THAN EV FROM EYLEA IS $6b. Price target would be "Miljenko Zuanic-2/13/2018
2300This is what Credit Suisse had to say about the Roche trial last week before newBiotech Jim-2/13/2018
2299Baseline mean CST was ~500 microns, and 75-80% have 20/40 or worse vision.....iMiljenko Zuanic-2/13/2018
2298RG7716 preliminary P2 DME results: gene.com Preclinical antibody characterizatioMiljenko Zuanic-2/12/2018
2297Praulent is not a big driver, if it fails so what? Exactly where they are now. Felix B-2/9/2018
2296<Yes 3/10 is when they are releasing praulent outcome, I don't have a lotMiljenko Zuanic-2/9/2018
2295Nope not worried, fundamentals haven't changed. In it for the long game, howFelix B-2/9/2018
2294<...hence I am not too worried about Eylea.> Well, regardless Eylea stronMiljenko Zuanic-2/9/2018
2293I just can't believe how poorly Kevzara is doing given both it's price aFelix B-2/9/2018
2292To continue on the same topic, <We reaffirm our full year 2018 guidance for SMiljenko Zuanic-2/8/2018
2291In the absence of the any comment on this "great" 4Q (4Q was actually Miljenko Zuanic-2/8/2018
2290REGN 4Q CC: PATHETIC!Miljenko Zuanic-2/8/2018
2289Any positive in news/PR is used for "dump on market" mentality. EyleMiljenko Zuanic-2/8/2018
2288Dupi and Pral come at numbers that I was expecting/calculating, the only unknownMiljenko Zuanic-2/7/2018
2287Earnings guess? I don't see them saying anything too surprising and Eylea nFelix B-2/7/2018
2286I also used some REGN shares as gifts to a couple of academic institutions in 20Biotech Jim-2/6/2018
2285RE: AMZN It is not secret that I am trying to be short on AMZN, ..not successfuMiljenko Zuanic-2/5/2018
2284Message 31470351 <We should have transferred our REGN assets into VKTX in JuMiljenko Zuanic-2/5/2018
2283Well, $325 is a multi-year low, so it will be interesting see if the stock breakThe Ox-2/2/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News